International panel supports sNPWT as a preventive measure to help reduce the incidence of SSCs
Surgical site complications (SSCs), especially infections, have a significant impact on patient health and can cost the healthcare system billions of dollars. This article presents a potential remedy to this challenge, detailing the methods and results of an international multispecialty advisory panel convened to assess single use negative pressure wound therapy (sNPWT) used preemptively to help reduce SSCs.
The consensus panel agreed that sNPWT could mitigate SSC risk factors and supported its use as a prophylactic treatment for high-risk patients as well as patients at potential risk.
The article includes an in-depth review of the specific device used in the study: the lightweight, disposable PICOTM System, which differs from conventional NPWT in that its unique mechanism of action allows it to be canister-free, making it discreet and portable for patient mobility and convenience.
By selecting the “yes” option when filling out the above form, you agree to have your contact information passed along for the purpose of following up on your interests and in order to receive communications regarding Illumina products, services, and events. The data sent will be processed in Canada and provided to Illumina who will assume responsibility for processing and opt-out and information removal. Once your information has been processed by Illumina, communication preferences and opt-out can be managed directly on the Illumina website. For more information, please refer to the Illumina privacy policy.